Tirzepatide

Tirzepatide is a dual GIP and GLP-1 agonist approved for the treatment of type 2 diabetes and also used off-label for obesity treatment

Side Effects

  • Pancreatitis
  • Nausea
  • Vomiting
  • Abdominal pain

References

Retrieved from "https://www.wikem.org/w/index.php?title=Tirzepatide&oldid=389022"